Romiplostim

Indication

Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura (NICE TA221)

NICE TA221 - Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura

Red

Brand:

Nplate®

Nice TA:

221

Commissioning responsibility:

CCG

PbR excluded:

Yes

BNF chapter:

Blood and Nutrition

Background

Romiplostim is recommended as an option for treating chronic immune (idiopathic) thrombocytopenic purpura in adults, only if:
• their condition is refractory to standard active treatments and rescue therapies or
• they have severe disease and a high risk of bleeding that needs frequent courses of rescue therapies.
Romiplostim is recommended only if the company makes it available with the discount agreed in the patient access scheme.

Recommendation

LSCMMG Recommendation:

Red

Reason for decision:

Specialist medicine

Supporting documents:

Decisions of Lancashire local decision making groups

BwD	BP	CSR	EL	FW	GP	MB	WL
Red	Red	Red	Red	Red	Red	Red	Red

What do the colours mean?

Last Updated: 01 - Nov - 2018